BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mu W, Wang Z, Zöller M. Ping-Pong-Tumor and Host in Pancreatic Cancer Progression. Front Oncol 2019;9:1359. [PMID: 31921628 DOI: 10.3389/fonc.2019.01359] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Osei-Bordom DC, Serifis N, Brown ZJ, Hewitt DB, Lawal G, Sachdeva G, Cloonan DJ, Pawlik TM. Pancreatic ductal adenocarcinoma: Emerging therapeutic strategies. Surg Oncol 2022;43:101803. [PMID: 35830772 DOI: 10.1016/j.suronc.2022.101803] [Reference Citation Analysis]
2 Li Y, Zhao W, Wang Y, Wang H, Liu S. Extracellular vesicle-mediated crosstalk between pancreatic cancer and stromal cells in the tumor microenvironment. J Nanobiotechnology 2022;20:208. [PMID: 35501802 DOI: 10.1186/s12951-022-01382-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Yang L, Zhang W, Li M, Dam J, Huang K, Wang Y, Qiu Z, Sun T, Chen P, Zhang Z, Zhang W. Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer. Front Genet 2022;13:783016. [DOI: 10.3389/fgene.2022.783016] [Reference Citation Analysis]
4 Sun L, Chen S, Chen M. Schwann Cells in the Tumor Microenvironment: Need More Attention. J Oncol 2022;2022:1058667. [PMID: 35186076 DOI: 10.1155/2022/1058667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Tan Z, Wan R, Chen M, Xie P, Li P, Shen Y, Pan Z, Qian H. Expression of Tspan8 in Patients with Intrahepatic Cholangiocarcinoma and Its Relationship with Clinicopathological Features and Prognosis. Evid Based Complement Alternat Med 2021;2021:7475938. [PMID: 34721643 DOI: 10.1155/2021/7475938] [Reference Citation Analysis]
6 Mu W, Xu Y, Gu P, Wang W, Li J, Ge Y, Wang H. Exosomal CD44 Cooperates with Integrin α6β4 to Support Organotropic Metastasis via Regulating Tumor Cell Motility and Target Host Cell Activation. Engineering 2021;7:1413-23. [DOI: 10.1016/j.eng.2020.08.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Estaras M, Gonzalez A. Modulation of cell physiology under hypoxia in pancreatic cancer. World J Gastroenterol 2021; 27(28): 4582-4602 [PMID: 34366624 DOI: 10.3748/wjg.v27.i28.4582] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
8 Geng X, Chen H, Zhao L, Hu J, Yang W, Li G, Cheng C, Zhao Z, Zhang T, Li L, Sun B. Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer. Front Cell Dev Biol 2021;9:655152. [PMID: 34336821 DOI: 10.3389/fcell.2021.655152] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
9 Hernández-Camarero P, López-Ruiz E, Marchal JA, Perán M. Cancer: a mirrored room between tumor bulk and tumor microenvironment. J Exp Clin Cancer Res 2021;40:217. [PMID: 34183054 DOI: 10.1186/s13046-021-02022-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
10 Gu P, Sun M, Li L, Yang Y, Jiang Z, Ge Y, Wang W, Mu W, Wang H. Breast Tumor-Derived Exosomal MicroRNA-200b-3p Promotes Specific Organ Metastasis Through Regulating CCL2 Expression in Lung Epithelial Cells. Front Cell Dev Biol 2021;9:657158. [PMID: 34249913 DOI: 10.3389/fcell.2021.657158] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
11 Li J, Chen X, Zhu L, Lao Z, Zhou T, Zang L, Ge W, Jiang M, Xu J, Cao Y, Du S, Yu Y, Fan G, Wang H. SOX9 is a critical regulator of TSPAN8-mediated metastasis in pancreatic cancer. Oncogene 2021;40:4884-93. [PMID: 34163029 DOI: 10.1038/s41388-021-01864-9] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
12 Su C, Zhang J, Yarden Y, Fu L. The key roles of cancer stem cell-derived extracellular vesicles. Signal Transduct Target Ther 2021;6:109. [PMID: 33678805 DOI: 10.1038/s41392-021-00499-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
13 Tripathi SC, Jolly MK, Mani SA, Levine H. Editorial: Characterizing the Multi-Faceted Dynamics of Tumor Cell Plasticity. Front Mol Biosci 2020;7:630276. [PMID: 33553244 DOI: 10.3389/fmolb.2020.630276] [Reference Citation Analysis]
14 Farran B, Nagaraju GP. Exosomes as therapeutic solutions for pancreatic cancer. Drug Discovery Today 2020;25:2245-56. [DOI: 10.1016/j.drudis.2020.09.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Novak I, Yu H, Magni L, Deshar G. Purinergic Signaling in Pancreas-From Physiology to Therapeutic Strategies in Pancreatic Cancer. Int J Mol Sci 2020;21:E8781. [PMID: 33233631 DOI: 10.3390/ijms21228781] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Tanase C, Gheorghisan-Galateanu AA, Popescu ID, Mihai S, Codrici E, Albulescu R, Hinescu ME. CD36 and CD97 in Pancreatic Cancer versus Other Malignancies. Int J Mol Sci 2020;21:E5656. [PMID: 32781778 DOI: 10.3390/ijms21165656] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]